Literature DB >> 20862659

Measuring perfusion and bioenergetics simultaneously in mouse skeletal muscle: a multiparametric functional-NMR approach.

C Baligand1, C Wary, J C Ménard, E Giacomini, J-Y Hogrel, P G Carlier.   

Abstract

A totally noninvasive set-up was developed for comprehensive NMR evaluation of mouse skeletal muscle function in vivo. Dynamic pulsed arterial spin labeling-NMRI perfusion and blood oxygenation level-dependent (BOLD) signal measurements were interleaved with (31)P NMRS to measure both vascular response and oxidative capacities during stimulated exercise and subsequent recovery. Force output was recorded with a dedicated ergometer. Twelve exercise bouts were performed. The perfusion, BOLD signal, pH and force-time integral were obtained from mouse legs for each exercise. All reached a steady state after the second exercise, justifying the pointwise summation of the last 10 exercises to compensate for the limited (31)P signal. In this way, a high temporal resolution of 2.5  s was achieved to provide a time constant for phosphocreatine (PCr) recovery (τ(PCr)). The higher signal-to-noise ratio improved the precision of τ(PCr) measurement [coefficient of variation (CV) = 16.5% vs CV = 49.2% for a single exercise at a resolution of 30  s]. Inter-animal summation confirmed that τ(PCr) was stable at steady state, but shorter (89.3 ± 8.6  s) than after the first exercise (148  s, p < 0.05). This novel experimental approach provides an assessment of muscle vascular response simultaneously to energetic function in vivo. Its pertinence was illustrated by observing the establishment of a metabolic steady state. This comprehensive tool offers new perspectives for the study of muscle pathology in mice models.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20862659     DOI: 10.1002/nbm.1587

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  6 in total

Review 1.  Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials.

Authors:  Pierre G Carlier; Benjamin Marty; Olivier Scheidegger; Paulo Loureiro de Sousa; Pierre-Yves Baudin; Eduard Snezhko; Dmitry Vlodavets
Journal:  J Neuromuscul Dis       Date:  2016-03-03

2.  Localized semi-LASER dynamic (31)P magnetic resonance spectroscopy of the soleus during and following exercise at 7 T.

Authors:  Georg B Fiedler; Martin Meyerspeer; Albrecht I Schmid; Sigrun Goluch; Kiril Schewzow; Elmar Laistler; Arash Mirzahosseini; Fabian Niess; Ewald Unger; Michael Wolzt; Ewald Moser
Journal:  MAGMA       Date:  2015-04-18       Impact factor: 2.310

Review 3.  Interleaved and simultaneous multi-nuclear magnetic resonance in vivo. Review of principles, applications and potential.

Authors:  Alfredo L Lopez Kolkovsky; Pierre G Carlier; Benjamin Marty; Martin Meyerspeer
Journal:  NMR Biomed       Date:  2022-04-27       Impact factor: 4.478

4.  Combined MRI and ³¹P-MRS investigations of the ACTA1(H40Y) mouse model of nemaline myopathy show impaired muscle function and altered energy metabolism.

Authors:  Charlotte Gineste; Yann Le Fur; Christophe Vilmen; Arnaud Le Troter; Emilie Pecchi; Patrick J Cozzone; Edna C Hardeman; David Bendahan; Julien Gondin
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

5.  Comparing localized and nonlocalized dynamic 31P magnetic resonance spectroscopy in exercising muscle at 7 T.

Authors:  Martin Meyerspeer; Simon Robinson; Christine I Nabuurs; Tom Scheenen; Adrian Schoisengeier; Ewald Unger; Graham J Kemp; Ewald Moser
Journal:  Magn Reson Med       Date:  2012-02-14       Impact factor: 4.668

6.  Skeletal muscle ATP synthesis and cellular H(+) handling measured by localized (31)P-MRS during exercise and recovery.

Authors:  Georg B Fiedler; Albrecht I Schmid; Sigrun Goluch; Kiril Schewzow; Elmar Laistler; Fabian Niess; Ewald Unger; Michael Wolzt; Arash Mirzahosseini; Graham J Kemp; Ewald Moser; Martin Meyerspeer
Journal:  Sci Rep       Date:  2016-08-26       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.